Tech Industry Unhappy With US Patent Reform Bill
The high technology remains unconvinced by efforts in the United States Senate to reform US patent laws, a Washington tech industry association said today, as debate on the bill began on the Senate floor.

On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.